查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2028 年的栓塞治療市場預測 - COVID-19 的影響以及按產品、疾病適應症、程序和最終用戶進行的全球分析
市場調查報告書
商品編碼
1126256

到 2028 年的栓塞治療市場預測 - COVID-19 的影響以及按產品、疾病適應症、程序和最終用戶進行的全球分析

Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Disease Indication, Procedure, and End User
出版日期: | 出版商: The Insight Partners | 英文 255 Pages | 訂單完成後即時交付

價格

栓塞治療市場預計將從 2021 年的 33.4149 億美元增長到 2028 年的 57.5828 億美元，預計 2022 年至 2028 年的複合年增長率為 8.1%。

本報告涵蓋了市場上普遍存在的趨勢以及推動栓塞治療市場增長的因素。市場增長歸因於癌症患者發病率的上升、患者對微創手術的偏好上升、高血壓、肥胖、吸煙和酗酒的發病率上升。然而，其他替代療法的可用性和栓塞劑的高成本限制了市場增長。

栓塞療法是一種使用血管造影導管引入球囊、血栓、線圈和凝膠泡沫以阻塞動脈的治療方法。導管通過植入球囊或任何異物來幫助阻塞血管，用於治療出血性潰瘍、瘺管和動靜脈畸形的閉合、器官的血管切斷、血管缺損和無法手術的出血的控制。栓塞也可用於在手術期間阻止血液流向腫瘤及其周圍。

有五種典型的癌症類型：乳腺癌、前列腺癌、宮頸癌、肺癌和結腸癌。然而，在這五種癌症中，肺癌是癌症相關死亡的主要原因。儘管乳腺癌在女性中的發病率至少高出 25%，但宮頸癌仍是 2020 年的首要死因。根據國家癌症登記處 (NCR) 的數據，2020 年南非將診斷出約 110,000 例新癌症病例，超過 56,000 例與癌症相關的死亡，佔與非傳染性疾病相關的過早死亡的 4%，佔其中之一預計未來幾十年這一重大癌症負擔將增加，新癌症病例的發病率預計將在 2030 年和 2040 年分別上升到 138,000 和 175,000。此外，在同一時期，與癌症相關的死亡率預計將從 73,000 增加到 94,000。此外，據《美國癌症協會雜誌》報導，預計 2021 年美國將新診斷出 190 萬例癌症病例，將有 608,570 人死於癌症。此外，丹麥的男性和女性癌症綜合發病率最高，為每 10 萬人 334.9 例。十個國家的年齡標準化率為每 100,000 人 300 人或更多。丹麥、匈牙利、愛爾蘭、比利時、法國、澳大利亞、荷蘭、挪威、法國（新喀裡多尼亞）、斯洛文尼亞。 2018 年，德國估計有 233,000 名女性和 265,000 名男性新診斷出患有癌症。大約 10 年來，每年的新病例總數一直停滯在約 500,000 例。因此，癌症患者的增加產生了對栓塞產品的高需求。

栓塞治療市場按產品分為栓塞劑和支持裝置。栓塞劑進一步細分為微球、液體栓塞劑、栓塞線圈、栓塞系統、可拆卸球囊等。支持裝置進一步分為微導管和導絲。 2021年，栓塞劑細分市場將佔據最大的市場份額。此外，預計同一細分市場在預測期內的複合年增長率最高。栓塞劑部分增長的主要驅動力是栓塞劑的使用增加以及栓塞劑在各種介入放射學程序中的進步。

栓塞治療市場根據適應症分為癌症、外周血管疾病、神經系統疾病、泌尿/腎臟疾病、胃腸道疾病等。癌症細分為肝癌、腎癌等。預計到 2021 年，癌症領域將佔據最大的市場份額。此外，該細分市場預計將在 2022 年至 2028 年期間實現最快的複合年增長率。癌症部分增長的主要驅動力是全球癌症發病率的上升。

栓塞治療市場根據疾病適應症分為經導管動脈栓塞術（TAE）、經導管動脈放射栓塞術（TARE）/選擇性內放療（SIRT）和經動脈化療栓塞術（TACE）。 2021年，經導管動脈栓塞（TAE）細分市場預計將佔據最大的市場份額。此外，預計該細分市場將在 2022 年至 2028 年期間實現最快的複合年增長率。經導管動脈栓塞 (TAE) 領域增長的主要驅動力是老年人對微創手術的偏好增加、慢性病患病率增加以及老年人口迅速增加。

在最終用戶的基礎上，栓塞治療市場細分為醫院和診所、門診手術中心和其他最終用戶。到 2021 年，醫院和診所部分預計將佔據最大的市場份額。此外，預計該細分市場將在 2022 年至 2028 年期間實現最高的複合年增長率。醫院和診所部門的增長主要是由於微創外科手術（包括血管、泌尿外科和神經外科）的採用增加；其中包括在機構中進行的栓塞手術數量增加，以及採用先進和先進的手術方式的增加。 - 最先進的栓塞設備，可在大型醫院、小型診所和重症監護室準確執行複雜的程序。

COVID-19 的影響 - 栓塞治療市場

在這種情況下，頭頸部手術等癌症、腦動脈瘤等慢性神經系統疾病、頭痛和神經退行性疾□□病的治療顯然伴隨著巨大的困難。結果，癌症和神經系統疾病的症狀惡化，許多患者被送往急診室。在 COVID-19 大流行期間，患有神經系統疾病（例如癌症和中風）的患者有時會在治療窗口之外的醫院進行緊急干預，從而遲到。確保重症監護病房的床位以管理急性疾病也已成為一項挑戰。

這最初導致醫院取消了所有擇期手術和程序。儘管肌瘤通常沒有威脅性，但它們對一些患者的生活質量產生了重大影響。因此，為了遏制病毒的交叉傳播，或安排醫院安排以支持受感染的患者，對獲得選擇性治療的機會施加了限制，導致女性感到不適，幾乎沒有人最終接受了效果顯著的臨時治療。因此，醫院和公共機構在 COVID-19 流行期間繼續進行子宮肌瘤栓塞術（UFE）。這些因素最初被認為對市場增長有負面影響。

栓塞治療市場的公司正在採用各種有機和無機策略。有機戰略主要包括產品發布和產品批准。此外，市場上見證的無機增長戰略是收購、合作和夥伴關係。這些增長戰略將使栓塞治療市場參與者能夠擴大業務並加強其地域影響力，從而促進整個市場的增長。此外，收購和合作戰略有助於市場參與者加強其客戶群並擴大其產品組合。下面列出了栓塞治療市場主要參與者的一些重大發展。

2022 年 4 月，Boston Scientific Corporation的 EMBOLD 纖維可拆卸線圈獲得了美國食品和藥物管理局 (FDA) 的 510(k) 許可，該線圈旨在抑製或減少外周血流。作為Boston Scientific Corporation介入腫瘤學產品組合的新成員，EMBOLD 纖維線圈是一種微創治療，旨在通過阻塞一個或多個血管來阻塞或減少血流。設計用於栓塞。

2021 年 9 月，Abbott Laboratories宣布收購了 Walk Vascular, LLC，這是一家商業階段的醫療器械公司，擁有旨在去除外周血栓的微創機械抽吸血栓切除術系統。 Walkvascular 的外周血栓切除系統將整合到Abbott Laboratories現有的血管內產品組合中。

在準備栓塞治療市場報告時，參考了世界衛生組織 (WHO)、美國疾病控制中心 (CDC) 和英國製藥商協會 (ABPI) 等主要和次要來源。

內容

第一章介紹

  • 調查範圍
  • Insight Partners 研究報告指南
  • 市場細分
    • 全球栓塞治療市場 - 按產品分類
    • 全球栓塞市場 - 按疾病適應症
    • 全球栓塞市場 - 按程序
    • 全球栓塞治療市場 - 按最終用戶
    • 栓塞療法全球市場-按地區

第 2 章栓塞市場 - 要點

第三章研究方法

  • 適用範圍
  • 二次調查
  • 初步調查

第 4 章全球栓塞治療市場 - 市場格局

  • PEST 分析
    • 北美 - PEST 分析
    • 歐洲 - PEST 分析
    • 亞太地區 - PEST 分析
    • 中東和非洲 - PEST 分析
    • 拉丁美洲 - PEST 分析
  • 專家意見

第 5 章栓塞治療市場 - 主要市場動態

  • 市場驅動力
    • 癌症患者的發病率增加
    • 患者對微創手術的偏好不斷上升
    • 高血壓、肥胖、吸煙和酗酒的發病率增加
  • 市場製約因素
    • 其他替代療法的可用性
    • 栓塞治療費用高
  • 市場機會
    • 擴大栓塞治療的應用範圍
  • 市場趨勢
    • 增加液體栓塞劑的使用
  • 影響分析

第 6 章栓塞治療市場 - 全球分析

  • 栓塞療法全球市場收入及預測/分析
  • 全球栓塞治療市場、地區預測和分析
    • 全球栓塞治療市場 - 市場潛力分析，按地區
  • 主要參與者的市場定位
    • 公司分析
    • 增長策略分析
    • 主要參與者的表現
      • Cook Medical LLC
      • Boston Scientific Corporation

第 7 章栓塞治療市場收入和到 2028 年的產品預測

  • 按產品分列的栓塞治療市場收入份額（2022 年和 2028 年）（%）
  • 栓塞劑
  • 支持的設備

第 8 章栓塞治療市場分析 - 按疾病適應症

  • 2022 年和 2028 年按疾病適應症劃分的栓塞治療市場收入份額 (%)
  • 癌症
  • 外周血管疾病
  • 神經系統疾病
  • 泌尿外科/腎臟疾病
  • 消化系統疾病
  • 其他

第 9 章栓塞治療市場分析 - 按程序

  • 2022 年和 2028 年栓塞治療市場收入份額（按程序）（%）
  • 經導管動脈栓塞術 (TAE)
  • 經導管動脈栓塞術 (TARE)/選擇性體內放療 (SIRT)
  • 經動脈化療栓塞術 (TACE)

第 10 章栓塞治療市場分析 - 按最終用戶分類

  • 按最終用戶劃分的栓塞治療市場收入份額（2022 年、2028 年）（%）
  • 醫院和診所
  • 門診手術中心
  • 其他最終用戶

第 11 章栓塞治療市場 - 區域分析

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲
    • 沙特阿拉伯
    • 南非
    • 阿聯酋
    • 其他中東和非洲
  • 中美洲和南美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲

第 12 章 COVID-19 大流行對全球栓塞治療市場的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第 13 章栓塞治療市場 - 行業格局

  • 市場進入者實施的增長戰略 (%)
  • 有機發展
  • 無機發展

第 14 章公司簡介

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Johnson & Johnson
  • Medtronic
  • Acandis GmbH
  • Balt USA LLC
  • Stryker Corporation
  • Guerbet LLC
Product Code: TIPRE00006432

The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028.

The report highlights trends prevailing in the market and factors driving the embolotherapy market growth. The market growth is attributed to a rising incidence of cancer cases, rising patient preference for minimally invasive procedures, and increasing incidence of hypertension, obesity, smoking, and alcoholism. However, the availability of other alternative therapies and the high cost of embolization agents limit the market growth.

Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils, or gel foam using an angiographic catheter. The catheter aids in blocking a blood vessel by implanting a balloon or any foreign body to treat bleeding ulcers, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defects, or control inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.

The five most common types of cancer are breast, prostate, cervical, lung, and colorectal. However, of these five cancers, the leading cause of cancer-related death is lung cancer. Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. According to National Cancer Registry (NCR), in 2020, ~110,000 new cancer cases were diagnosed in South Africa, with over 56,000 cancer-related deaths, representing a quarter of premature noncommunicable disease-related mortality. This significant cancer burden is predicted to increase in the coming decades, with the incidence of new cancer cases expected to rise to 138,000 and 175,000 by 2030 and 2040, respectively. Cancer-related mortality is predicted to rise to 73,000 and 94,000 during the same period. Moreover, according to the American Cancer Society journal, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Further, in Denmark, the highest cancer rate for men and women combined was 334.9 people per 100,000. The age-standardized rate was at least 300 per 100,000 for ten countries: Denmark, Hungary, Ireland, Belgium, France, Australia, The Netherlands, Norway, France (New Caledonia), and Slovenia. In 2018, an estimated 233,000 women and 265,000 men in Germany were newly diagnosed with cancer. The total number of new cases per year has stagnated at around 500,000 for about ten years. Thus, the rising prevalence of cancer cases is creating a high demand for embolotherapy products.

Based on the product, the embolotherapy market is bifurcated into embolic agents and support devices. The embolic agents are further sub-segmented into microsphere, liquid embolics agents, embolic coils, embolic plug systems, detachable balloons, and others. The support devices are further sub-segmented into microcatheters and guidewires. The embolic agents segment is likely to hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period. The major driving factors for the growth of the embolic agents segment are the increasing use of embolic agents in various interventional radiology procedures and advancements in embolic agents.

Based on disease indication, the embolotherapy market is segmented into cancer, peripheral vascular disease, neurological disease, urological and nephrological disorder, gastrointestinal disorder, and others. The cancer is sub-segmented into liver cancer, kidney cancer, and other. The cancer segment is likely to hold the largest market share in 2021. Moreover, the same segment is expected to record the fastest CAGR from 2022 to 2028. The major driving factors for the growth of the cancer segment are the rising incidences of cancer worldwide.

Based on disease indication, the embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization (TARE)/selective internal radiation therapy (SIRT), and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment is likely to hold the largest market share in 2021. Moreover, the same segment is expected to record the fastest CAGR from 2022 to 2028. The major driving factors for the growth of the transcatheter arterial embolization (TAE) segment are the rising preference for minimally invasive procedures by the elderly, the growing prevalence of chronic diseases, and the rapid growth in the geriatric population.

Based on end user, the embolotherapy market is segmented into hospital & clinic, ambulatory surgical center, and other end user. In 2021, the hospital & clinic segment will likely hold the market's largest share. Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028. The major driving factors for the growth of the hospitals & clinics segment are the growing adoption of minimally invasive surgical procedures (including vascular, urological, and neurological), higher patient footfall in hospitals for the treatment of various diseases such as cancer, an increasing number of embolization procedures performed in these facilities, growing adoption of advance and cutting-edge embolotherapy devices to perform complex procedures with precision in a big hospital, small clinics, and critical care units.

COVID-19 Impact - Embolotherapy Market

In this scenario, the world observed enormous difficulties in managing cancers such as head and neck surgeries, chronic neurological disorders like brain aneurysms, and from headaches to neurodegenerative diseases. Due to inadequate monitoring, many patients are admitted to emergency departments due to decompensation of their cancer and neurological disease. During the COVID-19 pandemic, cancer, stroke patients, and other neurological conditions have been arriving late at the hospital, outside the therapeutic window for acute intervention. In addition, the country also faced difficulties obtaining beds in the intensive care unit to manage the diseases during the acute phase.

The initial result was the cancellation of all elective hospital surgeries and procedures. While uterine fibroids are typically not threatened, some patients' quality of life has been significantly impacted. Thus, the constraints imposed on accessing elective treatments, either to reduce cross-transmission of the virus or to schedule the hospital structure to assist infected patients, have caused women to live with discomfort and temporary treatments with slight effectiveness. For this reason, hospitals and public organizations have continued to offer Uterine Fibroid Embolization (UFE) during the COVID-19 pandemic. These factors were likely to have a negative impact in the initial phase on the market growth.

Various organic and inorganic strategies are adopted by companies in the embolotherapy market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the embolotherapy market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few significant developments by key players in the embolotherapy market are listed below.

In April 2022, Boston Scientific Corporation received 510(k) clearance from the US Food and Drug Administration (FDA) for the EMBOLD Fibered Detachable Coil intended to impede or reduce blood flow in the peripheral vasculature. The newest addition to the Boston Scientific interventional oncology portfolio, the EMBOLD Fibered Coil, was designed for use in various embolization procedures, a minimally invasive treatment intended to block one or more blood vessels to obstruct or reduce blood flow.

In September 2021, Abbott announced that it acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular's peripheral thrombectomy systems will be incorporated into Abbott's existing endovascular product portfolio.

A few major primary and secondary sources referred to while preparing the report on the embolotherapy market are the World Health Organization (WHO), the Centers for Disease Control (CDC), and the Association of the British Pharmaceutical Industry (ABPI).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global embolotherapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global embolotherapy market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Embolotherapy Market - by Product
    • 1.3.2 Global Embolotherapy Market - by Disease Indication
    • 1.3.3 Global Embolotherapy Market - by Procedure
    • 1.3.4 Global Embolotherapy Market - by End User
    • 1.3.5 Global Embolotherapy Market- By Geography

2. Embolotherapy Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Embolotherapy Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East & Africa- PEST Analysis
    • 4.2.5 South & Central America - PEST Analysis
  • 4.3 Expert Opinion

5. Embolotherapy Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidence of Cancer Cases
    • 5.1.2 Rising Patient Preference for Minimally Invasive Procedures
    • 5.1.3 Increasing Incidence of Hypertension, Obesity, Smoking, and Alcoholism
  • 5.2 Market Restraints
    • 5.2.1 Availability of Other Alternative Therapies
    • 5.2.2 High Cost of Embolotherapy
  • 5.3 Market Opportunity
    • 5.3.1 Growing Applications of Embolotherapy
  • 5.4 Market Trend
    • 5.4.1 Increasing Use of Liquid Embolic Agents
  • 5.5 Impact analysis

6. Embolotherapy Market- Global Analysis

  • 6.1 Global Embolotherapy Market Revenue Forecast and Analysis
  • 6.2 Global Embolotherapy Market, By Geography - Forecast and Analysis
    • 6.2.1 Global Embolotherapy Market - Market Potential Analysis, By Region
  • 6.3 Market Positioning of Key Players
    • 6.3.1 Company Analysis
    • 6.3.2 Growth Strategy Analysis
    • 6.3.3 Performance Of Key Players
      • 6.3.3.1 Cook Medical LLC
      • 6.3.3.2 Boston Scientific Corporation

7. Embolotherapy Market Revenue and Forecasts To 2028 by Product

  • 7.1 Overview
  • 7.2 Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
  • 7.3 Embolic Agents
    • 7.3.1 Overview
    • 7.3.2 Embolic Agents: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    • 7.3.3 Microspheres
      • 7.3.3.1 Overview
      • 7.3.3.2 Microspheres: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    • 7.3.4 Embolic Coils
      • 7.3.4.1 Overview
      • 7.3.4.2 Embolic Coils: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    • 7.3.5 Embolic Plug Systems
      • 7.3.5.1 Overview
      • 7.3.5.2 Embolic Plug Systems: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    • 7.3.6 Detachable Balloons
      • 7.3.6.1 Overview
      • 7.3.6.2 Detachable Balloons: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    • 7.3.7 Liquid Embolic Agents
      • 7.3.7.1 Overview
      • 7.3.7.2 Liquid Embolic: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    • 7.3.8 Others
      • 7.3.8.1 Overview
      • 7.3.8.2 Others: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Support Devices
    • 7.4.1 Overview
    • 7.4.2 Support Devices: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    • 7.4.3 Microcatheters
      • 7.4.3.1 Overview
      • 7.4.3.2 Microcatheters: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    • 7.4.4 Guidewires
      • 7.4.4.1 Overview
      • 7.4.4.2 Guidewires: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)

8. Embolotherapy Market Analysis - By Disease Indication

  • 8.1 Overview
  • 8.2 Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
  • 8.3 Cancer
    • 8.3.1 Overview
    • 8.3.2 Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.1 Liver Cancer
        • 8.3.2.1.1 Overview
        • 8.3.2.1.2 Liver Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.2 Kidney Cancer
        • 8.3.2.2.1 Overview
        • 8.3.2.2.2 Kidney Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
      • 8.3.2.3 Other Cancers
        • 8.3.2.3.1 Overview
        • 8.3.2.3.2 Other Cancers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Peripheral Vascular Diseases
    • 8.4.1 Overview
    • 8.4.2 Peripheral Vascular Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Neurological Diseases
    • 8.5.1 Overview
    • 8.5.2 Neurological Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Urological and Nephrological Disorders
    • 8.6.1 Overview
    • 8.6.2 Urological and Nephrological Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Gastrointestinal Disorders
    • 8.7.1 Overview
    • 8.7.2 Gastrointestinal Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

9. Embolotherapy Market Analysis - By Procedure

  • 9.1 Overview
  • 9.2 Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
  • 9.3 Transcatheter Arterial Embolization (TAE)
    • 9.3.1 Overview
    • 9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
    • 9.4.1 Overview
    • 9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Transarterial Chemoembolization (TACE)
    • 9.5.1 Overview
    • 9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

10. Embolotherapy Market Analysis - By End User

  • 10.1 Overview
  • 10.2 Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgical Centers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Other End Users
    • 10.5.1 Overview
    • 10.5.2 Other End Users: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

11. Embolotherapy Market - Geographic Analysis

  • 11.1 North America: Embolotherapy Market
    • 11.1.1 Overview
    • 11.1.2 North America: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.1.3 North America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.3.1 North America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.3.2 North America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    • 11.1.4 North America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
      • 11.1.4.1 North America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    • 11.1.5 North America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    • 11.1.6 North America Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
    • 11.1.7 North America: Embolotherapy Market, by Country, 2022 & 2028 (%)
      • 11.1.7.1 US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.1 US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.2 US Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.2.1 US Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.2.2 US Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.3 US Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.3.1 US Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.4 US Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.1.5 US Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.1.7.2 Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.1 Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.2 Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.2.1 Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.2.2 Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.3 Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.3.1 Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.4 Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.2.5 Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.1.7.3 Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.1 Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.2 Mexico Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.2.1 Mexico Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.2.2 Mexico Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.3 Mexico Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.3.1 Mexico Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.4 Mexico Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.1.7.3.5 Mexico Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • 11.2 Europe: Embolotherapy Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.3 Europe Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
      • 11.2.3.1 Europe Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
      • 11.2.3.2 Europe Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.4 Europe Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
      • 11.2.4.1 Europe Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.5 Europe Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    • 11.2.6 Europe Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
    • 11.2.7 Europe: Embolotherapy Market, by Country, 2022 & 2028 (%)
      • 11.2.7.1 Germany: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.1.1 Germany: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.1.2 Germany Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.1.2.1 Germany Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.1.2.2 Germany Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.1.3 Germany Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.1.3.1 Germany Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.1.4 Germany Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.1.5 Germany Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.2.7.2 France: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.1 France: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.2 France Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.2.1 France Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.2.2 France Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.3 France Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.3.1 France Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.4 France Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.5 France Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.2.7.3 UK: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.1 UK: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.2 UK, Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.2.1 UK, Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.2.2 UK, Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.3 UK, Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.3.1 UK, Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.4 UK, Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.5 UK, Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.2.7.4 Italy: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.1 Italy: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.2 Italy Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.2.1 Italy Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.2.2 Italy Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.3 Italy Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.3.1 Italy Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.4 Italy Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.5 Italy Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.2.7.5 Spain: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.1 Spain: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.2 Spain Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.2.1 Spain Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.2.2 Spain Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.3 Spain Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.3.1 Spain Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.4 Spain Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.5 Spain Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.2.7.6 Rest of Europe: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.1 Rest of Europe: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.2 Rest of Europe Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.2.1 Rest of Europe Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.2.2 Rest of Europe Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.3 Rest of Europe Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.3.1 Rest of Europe Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.4 Rest of Europe Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.5 Rest of Europe Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • 11.3 Asia Pacific: Embolotherapy Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.3.3 Asia Pacific: Embolotherapy Market, by Product, - Revenue and Forecast to 2028 (US$ Million)
      • 11.3.3.1 Asia Pacific Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
      • 11.3.3.2 Asia Pacific Embolotherapy Market, by Support Device - Revenue and Forecast to 2028 (US$ Million)
    • 11.3.4 Asia Pacific Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
      • 11.3.4.1 Asia Pacific Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
      • 11.3.4.2 Asia Pacific Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    • 11.3.5 Asia Pacific: Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
    • 11.3.6 Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)
      • 11.3.6.1 China: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.1.1 Overview
        • 11.3.6.1.2 China: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.1.3 China Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.1.3.1 China Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.1.3.2 China Embolotherapy Market, by Support Device - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.1.4 China Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.1.4.1 China Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.1.5 China Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.1.6 China Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.3.6.2 Japan: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.2.1 Japan: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.2.2 Japan Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.2.2.1 Japan Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.2.2.2 Japan Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.2.3 Japan Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.2.3.1 Japan Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.2.4 Japan Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.2.5 Japan Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.3.6.3 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.6.3.1 Overview
        • 11.3.6.3.2 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.6.3.3 India: Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.3.3.1 India: Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.3.3.2 India: Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.3.4 India: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.3.4.1 India: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.3.5 India: Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.3.6 India: Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.3.6.4 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.6.4.1 Overview
        • 11.3.6.4.2 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.6.4.3 South Korea: Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.4.3.1 South Korea: Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.4.3.2 South Korea: Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.4.4 South Korea: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.4.4.1 South Korea: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.4.5 South Korea: Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.4.6 South Korea: Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.3.6.5 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.6.5.1 Overview
        • 11.3.6.5.2 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.3.6.5.3 Australia: Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.5.3.1 Australia: Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.5.3.2 Australia: Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.5.4 Australia: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.5.4.1 Australia: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.5.5 Australia: Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.5.6 Australia: Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.3.6.6 Rest of Asia Pacific: Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.6.1 Overview
        • 11.3.6.6.2 Rest of Asia Pacific: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.6.3 Rest of Asia Pacific: Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.6.3.1 Rest of Asia Pacific: Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.6.3.2 Rest of Asia Pacific: Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.6.4 Rest of Asia Pacific: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.6.4.1 Rest of Asia Pacific: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.6.5 Rest of Asia Pacific: Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.3.6.6.6 Rest of Asia Pacific: Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Middle East & Africa: Embolotherapy Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    • 11.4.3 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
      • 11.4.3.1 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
      • 11.4.3.2 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
    • 11.4.4 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
      • 11.4.4.1 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
    • 11.4.5 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
    • 11.4.6 Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
    • 11.4.7 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)
      • 11.4.7.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.4.7.1.3 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
        • 11.4.7.1.3.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
        • 11.4.7.1.3.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
        • 11.4.7.1.4 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
        • 11.4.7.1.4.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
        • 11.4.7.1.5 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
        • 11.4.7.1.6 Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 11.4.7.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.4.7.2.3 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
        • 11.4.7.2.3.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
        • 11.4.7.2.3.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
        • 11.4.7.2.4 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
        • 11.4.7.2.4.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
        • 11.4.7.2.5 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
        • 11.4.7.2.6 South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 11.4.7.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.4.7.3.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
        • 11.4.7.3.3.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
        • 11.4.7.3.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
        • 11.4.7.3.4 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
        • 11.4.7.3.4.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
        • 11.4.7.3.5 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
        • 11.4.7.3.6 UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
      • 11.4.7.4 Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
        • 11.4.7.4.3 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
        • 11.4.7.4.3.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
        • 11.4.7.4.3.2 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
        • 11.4.7.4.4 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
        • 11.4.7.4.4.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
        • 11.4.7.4.5 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
        • 11.4.7.4.6 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
  • 11.5 South and Central America: Embolotherapy Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.5.3 South and Central America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
      • 11.5.3.1 South and Central America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
      • 11.5.3.2 South and Central America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    • 11.5.4 South and Central America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
      • 11.5.4.1 South and Central America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    • 11.5.5 South and Central America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    • 11.5.6 South and Central America Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
    • 11.5.7 South and Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)
      • 11.5.7.1 Brazil: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.1 Brazil: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.2 Brazil Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.2.1 Brazil Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.2.2 Brazil Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.3 Brazil Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.3.1 Brazil Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.4 Brazil Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.1.5 Brazil Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.5.7.2 Argentina: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.1 Argentina: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.2 Argentina Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.2.1 Argentina Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.2.2 Argentina Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.3 Argentina Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.3.1 Argentina Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.4 Argentina Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.2.5 Argentina Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
      • 11.5.7.3 Rest of South and Central America: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.1 Rest of South and Central America: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.2 Rest of South and Central America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.2.1 Rest of South and Central America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.2.2 Rest of South and Central America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.3 Rest of South and Central America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.3.1 Rest of South and Central America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.4 Rest of South and Central America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
        • 11.5.7.3.5 Rest of South and Central America Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)

12. Impact of COVID-19 Pandemic on Global Embolotherapy Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
  • 12.5 South & Central America: Impact Assessment of COVID-19 Pandemic

13. Embolotherapy Market -Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Abbott Laboratories
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Boston Scientific Corporation
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Cook Medical LLC
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Johnson & Johnson
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Medtronic
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Acandis GmbH
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Balt USA LLC
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Stryker Corporation
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Guerbet LLC
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products

List Of Tables

  • Table 1. North America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. North America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. North America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 7. North America Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. US Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. US Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. US Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. US Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. US Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 14. US Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 21. Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Mexico Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Mexico Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Mexico Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Mexico Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Mexico Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Mexico Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Mexico Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Europe Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Europe Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Europe Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Europe Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Europe Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Europe Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Europe Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Germany Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Germany Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. Germany Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. Germany Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Germany Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Germany Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Germany Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 43. France Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. France Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. France Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. France Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. France Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. France Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 49. France Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 50. UK, Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. UK, Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. UK, Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. UK, Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. UK, Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. UK, Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 56. UK, Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Italy Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Italy Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. Italy Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. Italy Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. Italy Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Italy Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Italy Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Spain Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. Spain Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. Spain Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. Spain Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Spain Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Spain Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Spain Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 71. Rest of Europe Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. Rest of Europe Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Rest of Europe Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Rest of Europe Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Rest of Europe Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Rest of Europe Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Rest of Europe Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Asia Pacific: Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Asia Pacific Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Asia Pacific Embolotherapy Market, by Support Device - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Asia Pacific Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Asia Pacific Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 83. Asia Pacific Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 84. Asia Pacific Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 85. China Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 86. China Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 87. China Embolotherapy Market, by Support Device - Revenue and Forecast to 2028 (US$ Million)
  • Table 88. China Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 89. China Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  • Table 90. China Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 91. China Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 92. Japan Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 93. Japan Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 94. Japan Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 95. Japan Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 96. Japan Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
  • Table 97. Japan Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 98. Japan Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 99. India: Embolotherapy Market, By Product - Revenue And Forecast To 2028 (US$ Million)
  • Table 100. India: Embolotherapy Market, By Embolic Agents - Revenue And Forecast To 2028 (US$ Million)
  • Table 101. India: Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 102. India: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 103. India: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
  • Table 104. India: Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 105. India: Embolotherapy Market, By End User- Revenue And Forecast To 2028 (US$ Million)
  • Table 106. South Korea: Embolotherapy Market, By Product - Revenue And Forecast To 2028 (US$ Million)
  • Table 107. South Korea: Embolotherapy Market, By Embolic Agents - Revenue And Forecast To 2028 (US$ Million)
  • Table 108. South Korea: Embolotherapy Market, By Support Devices - Revenue And Forecast To 2028 (US$ Million)
  • Table 109. South Korea: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 110. South Korea: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
  • Table 111. South Korea: Embolotherapy Market, By Procedure - Revenue And Forecast To 2028 (US$ Million)
  • Table 112. South Korea: Embolotherapy Market, By End User- Revenue And Forecast To 2028 (US$ Million)
  • Table 113. Australia: Embolotherapy Market, By Product - Revenue And Forecast To 2028 (US$ Million)
  • Table 114. Australia: Embolotherapy Market, By Embolic Agents - Revenue And Forecast To 2028 (US$ Million)
  • Table 115. Australia: Embolotherapy Market, By Support Devices - Revenue And Forecast To 2028 (US$ Million)
  • Table 116. Australia: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 117. Australia: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
  • Table 118. Australia: Embolotherapy Market, By Procedure - Revenue And Forecast To 2028 (US$ Million)
  • Table 119. Australia: Embolotherapy Market, By End User- Revenue And Forecast To 2028 (US$ Million)
  • Table 120. Rest of Asia Pacific: Embolotherapy Market, By Product - Revenue And Forecast To 2028 (US$ Million)
  • Table 121. Rest of Asia Pacific: Embolotherapy Market, By Embolic Agents - Revenue And Forecast To 2028 (US$ Million)
  • Table 122. Rest of Asia Pacific: Embolotherapy Market, By Support Devices - Revenue And Forecast To 2028 (US$ Million)
  • Table 123. Rest of Asia Pacific: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 124. Rest of Asia Pacific: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
  • Table 125. Rest of Asia Pacific: Embolotherapy Market, By Procedure - Revenue And Forecast To 2028 (US$ Million)
  • Table 126. Rest Of Asia Pacific: Embolotherapy Market, By End User- Revenue And Forecast To 2028 (US$ Million)
  • Table 127. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million).
  • Table 128. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
  • Table 129. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
  • Table 130. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
  • Table 131. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
  • Table 132. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
  • Table 133. Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 134. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
  • Table 135. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
  • Table 136. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
  • Table 137. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
  • Table 138. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
  • Table 139. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
  • Table 140. Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 141. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
  • Table 142. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
  • Table 143. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
  • Table 144. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
  • Table 145. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
  • Table 146. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
  • Table 147. South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 148. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
  • Table 149. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
  • Table 150. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
  • Table 151. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
  • Table 152. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
  • Table 153. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
  • Table 154. UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 155. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
  • Table 156. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
  • Table 157. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
  • Table 158. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
  • Table 159. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
  • Table 160. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
  • Table 161. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
  • Table 162. South and Central America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 163. South and Central America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 164. South and Central America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 165. South and Central America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 166. South and Central America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
  • Table 167. South and Central America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 168. South and Central America Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 169. Brazil Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 170. Brazil Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 171. Brazil Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 172. Brazil Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 173. Brazil Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
  • Table 174. Brazil Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 175. Brazil Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 176. Argentina Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 177. Argentina Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 178. Argentina Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 179. Argentina Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 180. Argentina Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
  • Table 181. Argentina Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 182. Argentina Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 183. Rest of South and Central America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 184. Rest of South and Central America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  • Table 185. Rest of South and Central America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
  • Table 186. Rest of South and Central America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 187. Rest of South and Central America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
  • Table 188. Rest of South and Central America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
  • Table 189. Rest of South and Central America Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 190. Organic Developments Done By Companies
  • Table 191. Inorganic Developments Done by Companies
  • Table 192. Glossary of Terms, Embolotherapy Market

List Of Figures

  • Figure 1. Global Embolotherapy Market Segmentation
  • Figure 2. Embolotherapy Market, By Region
  • Figure 3. Embolotherapy Market Overview
  • Figure 4. Embolic Agents Held Largest Share of Product Segment in Embolotherapy Market
  • Figure 5. Embolotherapy Market in Asia Pacific Region to Show Remarkable Growth During Forecast Period
  • Figure 6. Global Embolotherapy Market, By Geography (US$ Million)
  • Figure 7. Global Embolotherapy Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Embolotherapy Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East & Africa PEST Analysis
  • Figure 13. South and Central America PEST Analysis
  • Figure 14. Embolotherapy Market Impact Analysis of Drivers and Restraints
  • Figure 15. Global Embolotherapy Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 16. Global Embolotherapy Market- By Geography Forecast and Analysis - 2022 & 2028
  • Figure 17. Global Embolotherapy Market - Market Potential Analysis, By Region
  • Figure 18. Market Positioning of Key Players in Global Embolotherapy Market
  • Figure 19. Global Embolotherapy Market - Comparative Company Analysis
  • Figure 20. Global Embolotherapy Market - Growth Strategy Analysis
  • Figure 21. Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
  • Figure 22. Embolic Agents: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Microspheres: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Embolic Coils: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Embolic Plug Systems: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Detachable Balloons: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Liquid Embolics: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Others: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Support Devices: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Microcatheters: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Guidewires: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
  • Figure 33. Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Liver Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Kidney Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Other Cancers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Peripheral Vascular Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Neurological Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Urological and Nephrological Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Gastrointestinal Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Others: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
  • Figure 43. Transcatheter Arterial Embolization (TAE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Transarterial Chemoembolization (TACE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
  • Figure 47. Hospitals: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Ambulatory Surgical Centers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Other End Users: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. North America: Embolotherapy Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 51. North America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. North America: Embolotherapy Market, by Country, 2022 & 2028 (%)
  • Figure 53. US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. Europe: Embolotherapy Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 57. Europe Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Europe: Embolotherapy Market, by Country, 2022 & 2028 (%)
  • Figure 59. Germany: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. France: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. UK: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Italy: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Spain: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Rest of Europe: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. Asia Pacific: Embolotherapy Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 66. Asia Pacific Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)
  • Figure 68. China: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. Japan: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 71. South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 72. Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 73. Rest Of Asia Pacific: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 74. Middle East & Africa: Embolotherapy Market Revenue Overview, by Country, 2022 (US$ Million)
  • Figure 75. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 76. Middle East & Africa Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)
  • Figure 77. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 78. South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 79. UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 80. Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 81. South and Central America: Embolotherapy Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 82. South and Central America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 83. South and Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)
  • Figure 84. Brazil: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 85. Argentina: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 86. Rest of South and Central America: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 87. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 88. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 89. Impact of COVID-19 Pandemic in Asia Pacific Countries
  • Figure 90. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 91. Impact of COVID-19 Pandemic in South & Central America Countries
  • Figure 92. Growth Strategies Done by the Companies in the Market, (%)